Corvus Pharmaceuticals, Inc. (CRVS)

20.70 -0.24 (-1.15%) USD  |  NASDAQ  |  Jan 30, 16:00
20.70 0.00 (0.00%) After-Hours: 20:00
More

Corvus Pharmaceuticals EPS Diluted (Quarterly) : -0.1226 for Sept. 30, 2025

EPS Diluted (Quarterly) Chart

View EPS Diluted (Quarterly) for CRVS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (Quarterly) Range, Past 5 Years

View EPS Diluted (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (Quarterly) Benchmarks

View EPS Diluted (Quarterly) Benchmarks
Start Trial
Regeneron Pharmaceuticals, Inc. 7.86
Plus Therapeutics, Inc. -0.0412
Geron Corp. -0.0276
Jaguar Health, Inc. -6.280
Krystal Biotech, Inc. 2.660

EPS Diluted (Quarterly) Related Metrics

Net Income (Quarterly) -10.16M
Total Expenses (Quarterly) 10.16M
Enterprise Value 1.481B
Earnings Yield -2.58%
Normalized Earnings Yield -3.686